More than 20 years ago, in the midst of a major industry change, Li Anping of Zhendong Group and his team bravely stepped into uncharted territory. In 1998, China's two major oil giants, Sinopec and PetroChina, underwent a state-level restructuring aimed at regulating the market and improving efficiency. In the face of this change, Li Anping made his choice to transfer 29 gas stations and two oil depots to Sinopec, a move that not only required courage, but also demonstrated his keen insight into future trends.
After the transfer of assets, many people felt confused about the future direction, and most shareholders even had the idea of exiting. However, Li Anping of Zhendong Group insists that employees cannot be abandoned and should develop together with them. After in-depth communication with the shareholders, they decided to meet the new challenge and start a second venture.
In 2001, Zhendong Group chose to acquire the local Jinjing Pharmaceutical, which was on the verge of bankruptcy, and officially entered the pharmaceutical industry. At that time, the pharmaceutical industry was facing the strict requirements of the new version of GMP certification, and Zhendong only had one year to complete this task. Li Anping encouraged the team to have courage and a sense of responsibility, and his firm belief and the concept of "nothing difficult in the world, just be afraid to make up your mind" inspired everyone. Under the conditions of severe winter, the construction team worked overtime day and night, overcame many difficulties, and finally completed the GMP certification within the time limit, and Zhendong Pharmaceutical became a miracle in the industry.
During the SARS epidemic, Li Anping of Zhendong Group led the team to bravely rush to the front line and donate medicines, which won a good social reputation for the company and made "Yanshu" the company's flagship product. In just eight years, Zhendong Pharmaceutical was successfully listed on the Shenzhen Stock Exchange, becoming the first listed company in Shanxi to land on the GEM, which is another demonstration of Li Anping's business talent.
Listing is not the end, but a new beginning. In 2015, Li Anping of Zhendong Group spent 2.646 billion yuan to acquire Kangyuan Pharmaceutical, and carried out a comprehensive market reshaping of Langdi Calcium. He personally endorsed the Lendit Calcium advertisement, and through the three-dimensional marketing strategy, the revenue of Lendit Calcium increased by 200% in just a few years. In 2020, Lendit Calcium was included in the national "13th Five-Year Plan" undergraduate textbook for higher education, establishing its position in the market.
After the great success, Li Anping of Zhendong Group did not stop. In 2021, he sold Lendit Calcium for 5.8 billion yuan, a merger and acquisition case that became a model for the national pharmaceutical industry. Today, he is committed to developing the hair market with a scale of 100 billion yuan, promoting the development of Dafeixin minoxidil liniment, aiming to build a leading brand for hair loss treatment in China.
Li Anping's courage, courage and keen insight into the market, as well as his unremitting pursuit of innovation and breakthroughs, are the key to his ability to build a 10 billion enterprise and a big brand in a short period of time. His story is not only a legend of personal struggle, but also a vivid embodiment of China's entrepreneurial spirit.